This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Genentech, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Jiaxiang Jiang in Geographic Atrophy Lesion Segmentation
Introduction
Jiaxiang Jiang is an accomplished inventor based in South San Francisco, CA. He has made significant contributions to the field of medical imaging, particularly in the segmentation of geographic atrophy lesions in the retina. His innovative approach utilizes advanced imaging techniques to enhance the diagnosis and treatment of retinal diseases.
Latest Patents
Jiang holds a patent for a method and system titled "Multimodal geographic atrophy lesion segmentation." This patent describes a technique for generating a geographic atrophy (GA) lesion segmentation mask that corresponds to GA lesions in the retina. The method involves using a set of fundus autofluorescence (FAF) images, along with infrared (IR) images or optical coherence tomography (OCT) images, to create a detailed segmentation mask. In some instances, a neural network is employed to improve the accuracy of the segmentation process.
Career Highlights
Jiaxiang Jiang is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to healthcare. His work at Genentech focuses on developing advanced imaging techniques that can significantly impact patient care in ophthalmology.
Collaborations
Jiang collaborates with talented professionals in his field, including Michael Gregg Kawczynski and Jasmine Patil. These collaborations enhance the research and development of innovative solutions in medical imaging.
Conclusion
Jiaxiang Jiang's contributions to the field of geographic atrophy lesion segmentation demonstrate his commitment to advancing medical technology. His innovative methods have the potential to improve diagnostic accuracy and patient outcomes in retinal health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
